Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The prediction of human response to ONO-4641, a sphingosine 1-phosphate receptor modulator, from preclinical data based on pharmacokinetic-pharmacodynamic modeling.
Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.
Neuronal expression of pathological tau accelerates oligodendrocyte progenitor cell differentiation.
Immunologic and MRI markers of the therapeutic effect of IFN-β-1a in relapsing-remitting MS.
The OPTimization of interferon for MS study: 375 microg interferon beta-1b in suboptimal responders.
Daclizumab discontinue letter for the US market
[The membrane stabilizing effect of glatiramer acetate in multiple sclerosis].
Fatal Acute Myeloid Leukemia With 11q23 MLL Gene Rearrangement Following Mitoxantrone Treatment in a Case of Childhood-onset Multiple Sclerosis.
Glatiramer acetate in the treatment of multiple sclerosis
Investigation of the mechanism of action of alemtuzumab in a human CD52 transgenic mouse model.
Phase 4 GI Tolerability Study of DMF in Patients With Relapsing Forms of MS in the US (MANAGE)
Interleukin-8 and RANTES levels in patients with relapsing-remitting multiple sclerosis (RR-MS) treated with cladribine.
FDA approval letter for daclizumab for the prophylaxis of acute organ rejection in patients receiving renal transplants
Biogen Idec's long-acting beta interferon moves ahead in MS
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
More to come: humoral immune responses in MS.
EMD Serono
Receptos to Deliver Scientific Presentations Regarding RPC1063 at the 2014 American Academy of Neurology (AAN) Annual Meeting
BTG plc Close Period Update
The epidemiology of multiple sclerosis in three Australian cities: Perth, Newcastle and Hobart.
The interplay between the intestinal microbiota and the brain.
Tcelna® (imilecleucel-T)
The effect of daclizumab on brain atrophy in relapsing-remitting multiple sclerosis.
Kif1b is essential for mRNA localization in oligodendrocytes and development of myelinated axons.
Tumefactive demyelination and a malignant course in an MS patient during and following fingolimod therapy.

Pages